In addition, survivin overexpression in CML patients was correlated with the percentage of Ph chromosome positive cells and BCR-ABL expression [142], indicating that it can be regulated by BCR-ABL tyrosine kinase. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.